• Publications
  • Influence
Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart
Sudden deaths of young competitive athletes are tragic events that continue to have a considerable impact on the lay and medical communities.1–17 These deaths are usually due to a variety ofExpand
  • 928
  • 43
  • PDF
Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.
OBJECTIVES This study was designed to define more completely the clinical spectrum and consequences of stress cardiomyopathy (SC) beyond the acute event. BACKGROUND Stress cardiomyopathy is aExpand
  • 665
  • 40
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
BACKGROUND The influence of left ventricular outflow tract obstruction on the clinical outcome of hypertrophic cardiomyopathy remains unresolved. METHODS We assessed the effect of outflow tractExpand
  • 1,034
  • 39
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States
Background—A clinical entity characterized by acute but rapidly reversible left ventricular (LV) systolic dysfunction and triggered by psychological stress is emerging, with reports largely confinedExpand
  • 990
  • 26
Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment.
Ventricular remodeling, first described in animal models of left ventricular (LV) stress and injury, occurs progressively in untreated patients after large myocardial infarction and in those withExpand
  • 443
  • 23
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
Hypertrophic cardiomyopathy (HCM) is the most common familial heart disease with vast genetic heterogeneity, demonstrated over the past 20 years. Mutations in 11 or more genes encoding proteins ofExpand
  • 481
  • 22
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
Background— Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in the young, although not all patients eligible for sudden death prevention with an implantableExpand
  • 504
  • 20
  • PDF
Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy
Background— End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remainExpand
  • 511
  • 19
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
OBJECTIVES Our aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic resonance (CMR), represents an arrhythmogenic substrate in hypertrophic cardiomyopathy (HCM). Expand
  • 583
  • 18
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
OBJECTIVES Our purpose was to characterize the pattern and distribution of left ventricular (LV) hypertrophy by cardiovascular magnetic resonance (CMR) to more precisely define phenotypic expressionExpand
  • 327
  • 18
  • PDF